Health

Biocytogen announces acquisition of a third Beacon Optofluidic system to support expanding Antibody Discovery Platform

BOSTON, Feb. 25, 2021 /PRNewswire/ -- Biocytogen, a company dedicated to accelerating therapeutic antibody discovery, has announced the acquisition of a third Beacon Optofluidic system. The new instrument, developed by Berkeley Lights, will support the expansion of Biocytogen's antibody discove...

2021-02-25 23:45 1712

New Data Presented at ACTRIMS Forum 2021 Indicate MAVENCLAD®-treated RMS Patients Mount Protective Antibody Response to Common Vaccines

DARMSTADT, Germany, Feb. 25, 2021 /PRNewswire/ -- Not intended for UK and U.S. based media Merck, a leading science and technology company, today announced the presentation of a new analysis from the MAGNIFY-MS study on MAVENCLAD® (cladribine tablets) in patients with relapsing multiple sclerosi...

2021-02-25 21:00 2758

I-Mab Announces First Patient Dosed in China Phase 3 Study of Eftansomatropin Alfa in Pediatric Patients with Growth Hormone Deficiency

SHANGHAI and GAITHERSBURG, Md., Feb. 25, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed in the phase 3 piv...

2021-02-25 21:00 4837

Huami Corporation Announces Name Change to Zepp Health

BEIJING and CUPERTINO, Calif., Feb. 25, 2021 /PRNewswire/ -- Huami Corp . today announced it is changing its name internationally to Zepp Health Corp. (NYSE: ZEPP) and the ticker symbol of its American depositary shares listed on the NYSE to "ZEPP" to better reflec...

2021-02-25 20:56 9162

111 to Announce Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results on March 18, 2021

SHANGHAI, Feb. 25, 2021 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that it will report its unaudited financial results...

2021-02-25 19:00 4418

Zhuyeqing The Epitome of Chinese Green Tea Ranks High in the "2021 Global Top 10 Luxury Tea Brands"

NEW YORK, Feb. 25, 2021 /PRNewswire/ -- On February 24, 2021, Chinese brand Zhuyeqingranked high in the "2021 Global Top 10 Luxury Tea Brands", a global list that is compiled exclusively by one of the top three brand valuation organizations, World Brand Lab, to rank the best international high-en...

2021-02-25 16:21 3881

Polyplastics Expands DURACON (R) POM PM Series with New High-flow Grade for Medical and Healthcare Industry

TOKYO, Feb. 25, 2021 /PRNewswire/ -- The Polyplastics Group is expanding its DURACON (R) polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market. The new grade, DURACON PM27S01N, offe...

2021-02-25 15:00 2791

Elekta appoints Johan Adebäck as Chief Financial Officer

STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Johan Adebäck has been appointed as permanent Chief Financial Officer with immediate effect. He has held the position of Acting CFO sinceJune 2, 2020. Prior to the Acting CFO position, Johan Adebäck had been Group Tr...

2021-02-25 14:52 5052

Astana Club: TOP-10 Risks for Eurasia Are Already Coming True in 2021

NUR-SULTAN, Kazakhstan, Feb. 25, 2021 /PRNewswire/ -- Astana Club , one of the most esteemed geopolitical forums for Europe and Asia, announces the latest edition of the international rating "TOP-10 Risks for Eurasia in 2021" ....

2021-02-25 09:00 2187

Gannex Announces U.S. IND Approval and Initiation of Global Development of THR-β Agonist ASC41 for NASH

SHANGHAI, Feb. 24, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of nonalcoholic steatohepatitis (NASH), today announces the Investigational New Drug Application (IND) approval ...

2021-02-25 08:30 3005

WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories

SHANGHAI, Feb. 25, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that the company has been named a winner of the 2021 CMO Leadership Awards for a fourth year in a row. The company is proud to ...

2021-02-25 08:00 2130

Turnaround on track at Comvita

TAURANGA, New Zealand, Feb. 24, 2021 /PRNewswire/ -- Headlines * Reported NPAT $3.5M vs. ($13M) in PCP * Reported EBITDA* $10.6M vs. ($8.8M) in PCP, an improvement of $19.4M * Reported revenue $98.9M, +5.5% vs. PCP * Double-digit top and bottom-line growth in focus growth markets * Net ...

2021-02-25 07:38 6653

New FDI World Dental Federation global survey reveals that two-thirds of countries are not allowing dentists to administer COVID-19 vaccines

Survey also shows that half of the responding countries have agreed to include dentists in their priority vaccination groups GENEVA, Feb. 25, 2021 /PRNewswire/ --  FDI World Dental Federation today  called for more countries to enable dentists to administe...

2021-02-25 07:01 2695

Genome & Company and Debiopharm Join Forces To Create New Highly Specific Therapies for Cancer Patients

SEOUL, South Korea, Feb. 24, 2021 /PRNewswire/ -- Genome & Company (314130, CEO: Jisoo Pae, Hansoo Park), a global leading immuno-oncology firm, and Debiopharm, a Swiss-based biopharmaceutical company specializing in oncology and infectious diseases, today announced having entered into a research ...

2021-02-25 07:00 2169

Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021

HONG KONG, Feb. 25, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for...

2021-02-25 05:16 10176

Game-Changing Wrinkle Reduction Device Receives Key Regulatory Clearance in Canada

Sofwave is crucial to your aesthetic practice. Learn Why! YOQNEAM, Israel, Feb. 25, 2021 /PRNewswire/ -- Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received clearance from Health Canada for its next-generat...

2021-02-25 01:00 1966

Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI

Insilico Medicine Achieves Industry First Nominating Preclinical Candidate for Idiopathic Pulmonary Fibrosis With Both Novel Drug Target and Novel Molecule Discovered by Artificial Intelligence HONG KONG, Feb. 25, 2021 /PRNewswire/ -- Insilico Medicine has demonstrated a breakthrough in Artifici...

2021-02-25 00:48 2744

First cancer centers begin using initial release of Elekta's MOSAIQ 3 series

ATLANTA, Feb. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that several cancer centers are the early adopters of the company's first release in the MOSAIQ® 3* series. Featuring increased automation and simplified user interfaces, MOSAIQ 3 is designed to significantly reduce workflo...

2021-02-25 00:46 4932

Zymergen Appoints Global Finance Expert Enakshi Singh as Chief Financial Officer

EMERYVILLE, Calif., Feb. 24, 2021 /PRNewswire/ -- Biofacturing leader Zymergen  today announced it has promotedEnakshi (Ena) Singh to Chief Financial Officer. Singh has helped Zymergen close more than$1B in equity financing and $100M in debt since joining Zymergen as vice president of finance in 2...

2021-02-24 22:30 4946

VLP BioTech, Inc. Announces an Immunotherapy Designed for the Treatment of Chronic HBV/HDV Infections

-  VLP BioTech Has Developed a Vaccine-Based Viral-Entry-Inhibitor for the Treatment of Chronic HBV/HDV. -  The Vaccine-Based Treatment Has Significant Advantages Compared to a Peptide-Based, Entry-Inhibitor (Hepcludex). SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- VLP BioTech, Inc., a private, pre...

2021-02-24 22:00 3007
1 ... 651652653654655656657 ... 858